论文部分内容阅读
报告在抗感染、吸氧、改善通气、小剂量强心及利尿剂等治疗基础上,静滴硫酸镁治疗35例慢性肺心病(CPHD)急性加重期患者,总有效率94.3%,无效率5.7%,与常规治疗的对照组总有效率74.3%、无效率25.7%相比差异显著,P值<0.05。低血钾、洋地黄中毒、心津失常的发生率也明显低于对照组,P值分别<0.001、0.01、0.05。未见副作用。故认为:镁盐佐治CPHD确有疗效,值得推广。
The report in the anti-infection, oxygen, ventilation, low-dose cardiac and diuretic therapy based on the intravenous magnesium sulfate treatment of 35 patients with chronic pulmonary heart disease (CPHD) in patients with acute exacerbations, the total effective rate was 94.3%, the inefficiency of 5.7 %, Compared with the conventional treatment of the control group, the total effective rate of 74.3%, ineffective rate of 25.7% significant difference, P value <0.05. Hypokalemia, digitalis poisoning, the incidence of cardiac disorders were significantly lower than the control group, P values were <0.001,0.01,0.05. No side effects. So that: magnesium salt treatment of CPHD indeed curative effect, it is worth promoting.